Abstract:Rationale: Short QT syndrome (SQT) is a rare but arrhythmogenic disorder featured by shortened ventricular repolarization and a propensity toward life-threatening ventricular arrhythmias and sudden cardiac death. Objective: This study aimed to investigate the single-cell mechanism of SQT using patient-specific and gene-corrected induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). Methods and Results: One SQT patient carrying missense mutation T618I in potassium voltage-gated channel subfamily H member 2 (KCNH2) was recruited as well as 2 healthy control subjects in this study. Control and SQT patient-specific iPSCs were generated from skin fibroblasts using nonintegrated Sendai virus. The KCNH2 T618I mutation was corrected by genome editing in SQT iPSC lines to generate isogenic controls. All iPSCs were differentiated into iPSC-CMs using monolayer-based differentiation protocol. SQT iPSC-CMs exhibited abnormal action potential phenotype featured by shortened action potential duration and increased beat-beat interval variability, when compared with control and gene-corrected iPSC-CMs. Furthermore, SQT iPSC-CMs showed KCNH2 gain-of-function with increased rapid delayed rectifying potassium current (IKr) density and enhanced membrane expression. Gene expression profiling of iPSC-CMs exhibited a differential cardiac ion-channel gene expression profile of SQT. Moreover, QTc of SQT patient and action potential durations of SQT iPSC-CMs were both normalized by quinidine, indicating that quinidine is beneficial to KCNH2 T618I of SQT. Importantly, shortened action potential duration phenotype observed in SQT iPSC-CMs was effectively rescued by a short-peptide scorpion toxin BmKKx2 with a mechanism of targeting KCNH2. Conclusions: We demonstrate that patient-specific and gene-corrected iPSC-CMs are able to recapitulate single-cell phenotype of SQT, which is caused by the gain-of-function mutation KCNH2 T618I. These findings will help elucidate the mechanisms underlying SQT and discover therapeutic drugs for treating the disease by using peptide toxins as lead compounds.

Pharmacological Rescue of Herg Currents Carried out by G604S and Wide Type Herg Co‐expression

NS1643 Enhances Ionic Currents in a G604S‐WT Herg Co‐expression System Associated with Long QT Syndrome 2

The G604s-Herg Mutation Alters the Biophysical Properties and Exerts A Dominant-Negative Effect on Expression of Herg Channels in Hek293 Cells

Rescue of expression and function of long QT syndrome-causing mutant hERG channels by enhancing channel stability in the plasma membrane

Molecular Insights into the Rescue Mechanism of an hERG Activator Against Severe LQT2 Mutations.

Correction of Defective Protein Trafficking of a Mutant HERG Potassium Channel in Human Long QT Syndrome

Electrophysiological Characteristics of the LQT2 Syndrome Mutation KCNH2-G572S and Regulation by Accessory Protein KCNE2

The role and mechanism of chaperones Calnexin/Calreticulin in which ALLN selectively rescues the trafficking defective of HERG-A561V mutation

L539 Fs/47, A Truncated Mutation of Human Ether-A-Go-Go-Related Gene (herg), Decreases Herg Ion Channel Currents in Hek 293 Cells

Identification of Small-Molecule Ion Channel Modulators in C. Elegans Channelopathy Models.

Novel Characteristics of a Trafficking-Defective G572R-hERG Channel Linked to Hereditary Long QT Syndrome

Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome

The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2

Long-QT Syndrome-Associated Missense Mutations in the Pore Helix of the HERG Potassium Channel

[Functional Expression of Congenital Long QT Syndrome Related HERG Mutation A561V in Vitro].

Computational insights into the mechanisms underlying structural destabilization and recovery in trafficking-deficient hERG mutants

RNA interference targeting E637K mutation rescues hERG channel currents and restores its kinetic properties

Long QT Syndrome-associated Mutations in the Per-Arnt-Sim (PAS) Domain of HERG Potassium Channels Accelerate Channel Deactivation

Electrophysiological characterization of a small molecule activator on human ether-a-go-go-related gene (hERG) potassium channel.

Long Qt Syndrome-Causing Mechanism for Y475c Mutation in Herg

Translational toxicology and rescue strategies of the hERG channel dysfunction: biochemical and molecular mechanistic aspects